Can I sue for Vioxx?

Can I sue for Vioxx?

If you or a loved one experienced any of the serious or deadly side effects due to use of Vioxx, consult with an experienced lawyer today. We can help you with your Vioxx lawsuit. You may be entitled to damages in a wrongful death or personal injury lawsuit.

How many deaths did Vioxx cause?

By the time Vioxx is withdrawn from market, an estimated 20 million Americans have taken the drug. Research later published in the medical journal Lancet estimates that 88,000 Americans had heart attacks from taking Vioxx, and 38,000 of them died.

How much did Merck make from Vioxx?

Merck has agreed to pay $4.85 billion to settle claims that its painkiller Vioxx caused heart attacks and strokes in thousands of users, the drugmaker said Friday.

Did the FDA APPROVe Vioxx?

FDA originally approved Vioxx in May 1999. The original safety database included approximately 5000 patients on Vioxx and did not show an increased risk of heart attack or stroke.

How long was Vioxx on market?

On 30 September 2004, Vioxx (rofecoxib), a non-steroidal anti-inflammatory drug (NSAID) that had been on the market since 1999, was suddenly withdrawn by its manufacturer MSD owing to concerns about its effect on cardiovascular health.

Is Vioxx back on the market?

Now, 14 years later, the small drug company Tremeau Pharmaceuticals has announced plans to bring the drug back to market for severe joint pain caused by haemophilia.

What went wrong with Vioxx?

Vioxx: The Downfall of a Drug Merck removed one of the world’s best-selling painkillers from the market in 2004 after a study showed Vioxx caused an increased risk of serious cardiovascular events, such as stroke and heart attack.

Did Merck know about Vioxx?

Expert: Merck Previously Knew of Vioxx Heart Risks : NPR. Expert: Merck Previously Knew of Vioxx Heart Risks A cardiologist testifies that drugmaker Merck had scientific evidence of Vioxx’s cardiac hazards as far back as 1999 — well before it pulled the drug from market in September 2004.

Why Vioxx was taken off the market?

Vioxx: The Downfall of a Drug Merck removed one of the world’s best-selling painkillers from the market in 2004 after a study showed Vioxx caused an increased risk of serious cardiovascular events, such as stroke and heart attack. Now, Merck agrees to pay $4.85B to end thousands of lawsuits.

Is Vioxx still prescribed?

Vioxx was once a popular drug to treat arthritis. But manufacturer Merck & Co. pulled it from the market in 2004 amid safety concerns.

Why was Vioxx removed from the market?

Merck & Co. announced Sept. 30 a voluntary worldwide withdrawal of rofecoxib (Vioxx) after a study showed patients taking the drug on a long-term basis face twice the risk of a heart attack compared with patients receiving placebo.

Is Vioxx still used today?

Vioxx was withdrawn from the U.S. market in 2004. The manufacturer of Vioxx has announced a voluntary withdrawal of the drug from the U.S. and worldwide market. This withdrawal is due to safety concerns of an increased risk of cardiovascular events (including heart attack and stroke) in patients taking Vioxx.

Is there a lawsuit against Merck for Vioxx?

Vioxx Lawsuits. Following Merck’s voluntary market withdrawal of its second biggest money maker, the arthritis painkiller Vioxx (rofecoxib), Merck faced mounting lawsuits involving claims of civil liability as well as charges of potential criminal wrongdoing.

What was the settlement for the Vioxx case?

A secondary civil settlement required an additional payout from Merck of $628 million to resolve allegations regarding off-label marketing of Vioxx and false statements about the drug’s cardiovascular safety.

Why was Vioxx taken off the market?

The company finally decided to pull Vioxx from shelves in 2004, after additional studies revealed an increased risk of strokes and heart attacks among patients taking the drug for 18 months or longer.

How long has the Vioxx products liability lawsuit been in Louisiana?

VIOXX Products Liability Litigation. Begun in 2005, this MDL was transferred to the Eastern District of Louisiana in New Orleans and spanned eight years of litigation. Just in its first year, the court noticed 310 depositions relating to 168 witnesses and comprising over 35,000 pages of testimony.